All Regulation articles – Page 9
-
BusinessWhat might UK Reach look like?
As the UK’s legal system finds its feet post-Brexit, stakeholders have mixed feelings about the changes it could bring
-
NewsUS chemical industry spent $61M to fend off PFAS regulations
Campaign finance records show how chemicals producers lobby against policies aimed to regulate persistent PFAS pollutants
-
BusinessCoca-Cola chemist convicted of trade secret theft
Xiaorong You stole files detailing BPA-free can coatings from seven major chemicals firms
-
NewsUS food agency targets ‘toxic elements’ in baby food
Strategy will focus on lead, mercury, arsenic and cadmium
-
BusinessGovernment clears merger of SinoChem and ChemChina
China’s chemicals giants will unite under a state-run holding company
-
OpinionWhy are impurity regulations different for food and drugs?
The pharmaceutical and food industries should work together more closely on genotoxic impurities
-
NewsPrinceton fined for export violations involving controlled pathogens
37 violations relate to exporting strains and recombinants of animal pathogen to foreign research facilities
-
NewsReach’s health benefits are four times greater than the costs
European Chemicals Agency report claims benefits from bloc’s chemical legislation run to €2.1 billion annually
-
NewsContentious Trump-era ‘secret science’ rule struck down
US court scraps Environmental Protection Agency regulation, finalised in the waning days of Trump’s presidency, that hindered agency’s use of non-public data in policymaking
-
BusinessBiggest venture yet of any pharma company into cannabis
Jazz Pharmaceuticals buys cannabinoid therapeutic firm for $7.2 billion, inheriting first plant-derived cannabinoid medicine ever approved by FDA
-
BusinessCovid vaccination efforts bolstered by trial results from J&J and Novavax
A miserable January ended with positive news on the vaccine front but new variants added complications
-
BusinessVaccine approvals offer hope as global Covid cases surge
A handful of vaccines are now approved and the first doses are being given to patients, with trials for many more candidates nearing completion
-
BusinessIndustry expects problems ahead after initial relief over Brexit deal
Uncertainty still looms over regulation and logistics
-
BusinessChemicals industry roundup 2020
Pandemic provides impetus to re-tune supply chains for resilience and sustainability
-
BusinessPharmaceuticals roundup 2020
Alongside the race for Covid-19 treatments and vaccines, the industry has maintained momentum
-
ResearchExplainer: How would UK science be affected by a no-deal Brexit?
Access to EU science schemes, freedom of movement and student places are all expected to be disrupted
-
BusinessPfizer–BioNTech vaccine gains emergency approvals in US, Canada and beyond
UK begins vaccinating vulnerable populations after early authorisation
-
BusinessUK grants Pfizer–BioNTech Covid-19 vaccine emergency approval
Regulators around the world working towards accelerated decisions on vaccine data
-
BusinessBrexit may put some chemicals out of GB’s Reach
Industry fears divergence of UK and EU regulations could spell disaster for trade
-
